Track Homology Medicines, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Homology Medicines, Inc. FIXX · Stock Open Homology Medicines, Inc. in new tab

5.09 USD
ROE
-90.02
Beta
-0.11
Loading chart...
Key Metrics
Earnings dateMay 5, 2026
Debt/Equity1.81
% Insiders9.290%
Growth
Revenue Growth-1.00%
Estimates
Forward P/E-20.21

DCF valuation

Model fair value for Homology Medicines, Inc. (FIXX)
Result
Sign in to run the valuation for FIXX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Homology Medicines, Inc. Logo Homology Medicines, Inc. Analysis (FIXX)

United States Health Care Official Website Stock

Is Homology Medicines, Inc. a good investment? Homology Medicines, Inc. (FIXX) is currently trading at 5.09 USD.

Earnings Schedule: Homology Medicines, Inc. is expected to release its next earnings report on May 5, 2026.

Investor FAQ

Does Homology Medicines, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Homology Medicines, Inc.?

Homology Medicines, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 5, 2026.

Company Profile

The fund invests at least 80% of its net assets (plus borrowings for investment purposes) in the underlying security and financial instruments with economic characteristics that, in combination, provide 200% leveraged exposure to the price of the underlying security, on a daily basis, consistent with the fund’s investment objective. It is non-diversified.

Exchange Ticker
NMS (United States) FIXX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion